# Rave Restaurant Group, Inc.: financial statements, quarterly

RAVE · Nasdaq · CIK 718332 · [Consumer staples](/sectors/consumer-staples.md) · fiscal year ends Jun 28

Pages: [Overview](/companies/rave.md) · [Financials](/companies/rave/financials.md) · [Filings](/companies/rave/filings.md) · [Insiders](/companies/rave/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/rave/financials.md?period=annual).

## Income statement

| Line item | Unit | Q1 FY2024 (2023-09-24) | Q2 FY2024 (2023-12-24) | Q3 FY2024 (2024-03-24) | Q4 FY2024 (2024-06-30) | Q1 FY2025 (2024-09-29) | Q2 FY2025 (2024-12-29) | Q3 FY2025 (2025-03-30) | Q4 FY2025 (2025-06-29) | Q1 FY2026 (2025-09-28) | Q2 FY2026 (2025-12-28) | Q3 FY2026 (2026-03-29) | Q4 FY2026 (2026-06-28) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $k | [3,087](/filings/0001140361-24-045542.md) | [2,746](/filings/0001140361-25-003278.md) | [2,962](/filings/0001140361-25-017905.md) | [3,355 d](/filings/0001140361-26-037514.md) | [3,050](/filings/0001140361-25-040686.md) | [2,869](/filings/0001140361-26-003800.md) | [2,966](/filings/0001140361-26-019447.md) | [3,154 d](/filings/0001140361-26-037514.md) | [3,213](/filings/0001140361-25-040686.md) | [3,042](/filings/0001140361-26-003800.md) | [3,223](/filings/0001140361-26-019447.md) | [3,432 d](/filings/0001140361-26-037514.md) |
| Cost of revenue | $k | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating income | $k | not reported | not reported | not reported | not reported | [609](/filings/0001140361-25-040686.md) | [664](/filings/0001140361-26-003800.md) | [855](/filings/0001140361-26-019447.md) | [1,119 d](/filings/0001140361-26-037514.md) | [752](/filings/0001140361-25-040686.md) | [742](/filings/0001140361-26-003800.md) | [957](/filings/0001140361-26-019447.md) | [1,023 d](/filings/0001140361-26-037514.md) |
| Interest expense | $k | [0.0](/filings/0001140361-23-051013.md) | [0.0](/filings/0001140361-24-005023.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $k | [132](/filings/0001140361-24-045542.md) | [(13.0)](/filings/0001140361-25-003278.md) | [200](/filings/0001140361-25-017905.md) | [300 d](/filings/0001140361-26-037514.md) | [169](/filings/0001140361-25-040686.md) | [144](/filings/0001140361-26-003800.md) | [228](/filings/0001140361-26-019447.md) | [377 d](/filings/0001140361-26-037514.md) | [206](/filings/0001140361-25-040686.md) | [205](/filings/0001140361-26-003800.md) | [255](/filings/0001140361-26-019447.md) | [340 d](/filings/0001140361-26-037514.md) |
| Net income | $k | [386](/filings/0001140361-25-017905.md) | [553](/filings/0001140361-25-017905.md) | [654](/filings/0001140361-25-017905.md) | [880 d](/filings/0001140361-26-037514.md) | [526](/filings/0001140361-26-019447.md) | [607](/filings/0001140361-26-019447.md) | [722](/filings/0001140361-26-019447.md) | [847 d](/filings/0001140361-26-037514.md) | [645](/filings/0001140361-26-019447.md) | [637](/filings/0001140361-26-019447.md) | [800](/filings/0001140361-26-019447.md) | [796 d](/filings/0001140361-26-037514.md) |
| Diluted EPS | $ per share | [0.03](/filings/0001140361-24-045542.md) | [0.04](/filings/0001140361-25-003278.md) | [0.04](/filings/0001140361-25-017905.md) | not reported | [0.04](/filings/0001140361-25-040686.md) | [0.04](/filings/0001140361-26-003800.md) | [0.05](/filings/0001140361-26-019447.md) | not reported | [0.05](/filings/0001140361-25-040686.md) | [0.04](/filings/0001140361-26-003800.md) | [0.06](/filings/0001140361-26-019447.md) | not reported |
| Basic EPS | $ per share | [0.03](/filings/0001140361-24-045542.md) | [0.04](/filings/0001140361-25-003278.md) | [0.04](/filings/0001140361-25-017905.md) | not reported | [0.04](/filings/0001140361-25-040686.md) | [0.04](/filings/0001140361-26-003800.md) | [0.05](/filings/0001140361-26-019447.md) | not reported | [0.05](/filings/0001140361-25-040686.md) | [0.04](/filings/0001140361-26-003800.md) | [0.06](/filings/0001140361-26-019447.md) | not reported |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: not reported
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q1 FY2024 (2023-09-24) | Q2 FY2024 (2023-12-24) | Q3 FY2024 (2024-03-24) | FY2024 (2024-06-30) | Q1 FY2025 (2024-09-29) | Q2 FY2025 (2024-12-29) | Q3 FY2025 (2025-03-30) | FY2025 (2025-06-29) | Q1 FY2026 (2025-09-28) | Q2 FY2026 (2025-12-28) | Q3 FY2026 (2026-03-29) | FY2026 (2026-06-28) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [5.9](/filings/0001140361-23-051013.md) | [5.3](/filings/0001140361-24-005023.md) | [6.3](/filings/0001140361-24-023848.md) | [2.9](/filings/0001140361-25-036080.md) | [1.4](/filings/0001140361-24-045542.md) | [2.9](/filings/0001140361-25-003278.md) | [0.7](/filings/0001140361-25-017905.md) | [2.9](/filings/0001140361-26-037514.md) | [1.4](/filings/0001140361-25-040686.md) | [0.6](/filings/0001140361-26-003800.md) | [1.1](/filings/0001140361-26-019447.md) | [1.1](/filings/0001140361-26-037514.md) |
| Current assets | $m | [7.6](/filings/0001140361-23-051013.md) | [7.1](/filings/0001140361-24-005023.md) | [8.2](/filings/0001140361-24-023848.md) | [9.5](/filings/0001140361-25-036080.md) | [10.3](/filings/0001140361-24-045542.md) | [10.4](/filings/0001140361-25-003278.md) | [10.2](/filings/0001140361-25-017905.md) | [11.5](/filings/0001140361-26-037514.md) | [12.2](/filings/0001140361-25-040686.md) | [13.0](/filings/0001140361-26-003800.md) | [14.4](/filings/0001140361-26-019447.md) | [15.8](/filings/0001140361-26-037514.md) |
| Total assets | $m | [14.7](/filings/0001140361-23-051013.md) | [14.2](/filings/0001140361-24-005023.md) | [15.0](/filings/0001140361-24-023848.md) | [15.8](/filings/0001140361-25-036080.md) | [16.3](/filings/0001140361-24-045542.md) | [16.1](/filings/0001140361-25-003278.md) | [15.7](/filings/0001140361-25-017905.md) | [16.6](/filings/0001140361-26-037514.md) | [17.0](/filings/0001140361-25-040686.md) | [17.5](/filings/0001140361-26-003800.md) | [18.6](/filings/0001140361-26-019447.md) | [19.5](/filings/0001140361-26-037514.md) |
| Current liabilities | $m | [2.4](/filings/0001140361-23-051013.md) | [1.7](/filings/0001140361-24-005023.md) | [1.9](/filings/0001140361-24-023848.md) | [2.0](/filings/0001140361-25-036080.md) | [2.0](/filings/0001140361-24-045542.md) | [1.4](/filings/0001140361-25-003278.md) | [1.6](/filings/0001140361-25-017905.md) | [1.7](/filings/0001140361-26-037514.md) | [1.6](/filings/0001140361-25-040686.md) | [1.5](/filings/0001140361-26-003800.md) | [1.7](/filings/0001140361-26-019447.md) | [1.7](/filings/0001140361-26-037514.md) |
| Total liabilities | $m | [3.9](/filings/0001140361-23-051013.md) | [3.1](/filings/0001140361-24-005023.md) | [3.2](/filings/0001140361-24-023848.md) | [3.1](/filings/0001140361-25-036080.md) | [3.0](/filings/0001140361-24-045542.md) | [2.3](/filings/0001140361-25-003278.md) | [2.4](/filings/0001140361-25-017905.md) | [2.4](/filings/0001140361-26-037514.md) | [2.2](/filings/0001140361-25-040686.md) | [2.0](/filings/0001140361-26-003800.md) | [2.1](/filings/0001140361-26-019447.md) | [2.2](/filings/0001140361-26-037514.md) |
| Current portion of debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Short-term borrowings | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [10.9](/filings/0001140361-25-017905.md) | [11.1](/filings/0001140361-25-017905.md) | [11.8](/filings/0001140361-25-017905.md) | [12.7](/filings/0001140361-26-037514.md) | [13.3](/filings/0001140361-26-019447.md) | [13.8](/filings/0001140361-26-019447.md) | [13.3](/filings/0001140361-26-019447.md) | [14.2](/filings/0001140361-26-037514.md) | [14.8](/filings/0001140361-26-019447.md) | [15.5](/filings/0001140361-26-019447.md) | [16.4](/filings/0001140361-26-019447.md) | [17.3](/filings/0001140361-26-037514.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Current portion of debt: not reported
- Short-term borrowings: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q1 FY2024 (2023-09-24) | Q2 FY2024 (2023-12-24) | Q3 FY2024 (2024-03-24) | Q4 FY2024 (2024-06-30) | Q1 FY2025 (2024-09-29) | Q2 FY2025 (2024-12-29) | Q3 FY2025 (2025-03-30) | Q4 FY2025 (2025-06-29) | Q1 FY2026 (2025-09-28) | Q2 FY2026 (2025-12-28) | Q3 FY2026 (2026-03-29) | Q4 FY2026 (2026-06-28) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $k | [628](/filings/0001140361-24-045542.md) | [(323) d](/filings/0001140361-25-003278.md) | [1,026 d](/filings/0001140361-25-017905.md) | [1,514 d](/filings/0001140361-26-037514.md) | [530](/filings/0001140361-25-040686.md) | [711 d](/filings/0001140361-26-003800.md) | [961 d](/filings/0001140361-26-019447.md) | [1,193 d](/filings/0001140361-26-037514.md) | [608](/filings/0001140361-25-040686.md) | [306 d](/filings/0001140361-26-003800.md) | [1,136 d](/filings/0001140361-26-019447.md) | [1,502 d](/filings/0001140361-26-037514.md) |
| Capital expenditure | $k | [22.0](/filings/0001140361-24-045542.md) | [16.0 d](/filings/0001140361-25-003278.md) | [30.0 d](/filings/0001140361-25-017905.md) | [8.0 d](/filings/0001140361-26-037514.md) | [0.0](/filings/0001140361-25-040686.md) | [44.0 d](/filings/0001140361-26-003800.md) | [0.0 d](/filings/0001140361-26-019447.md) | [12.0 d](/filings/0001140361-26-037514.md) | [8.0](/filings/0001140361-25-040686.md) | [9.0 d](/filings/0001140361-26-003800.md) | [32.0 d](/filings/0001140361-26-019447.md) | [0.0 d](/filings/0001140361-26-037514.md) |
| Share repurchases | $k | [0.0](/filings/0001140361-23-051013.md) | [0.0 d](/filings/0001140361-24-005023.md) | [0.0 d](/filings/0001140361-25-017905.md) | [0.0 d](/filings/0001140361-26-037514.md) | not reported | not reported | not reported | [(1.0) d](/filings/0001140361-26-037514.md) | not reported | not reported | not reported | [0.0 d](/filings/0001140361-26-037514.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q1 FY2023 (2022-09-25) | Q2 FY2023 (2022-12-25) | Q3 FY2023 (2023-03-26) | Q1 FY2024 (2023-09-24) | Q2 FY2024 (2023-12-24) | Q3 FY2024 (2024-03-24) | Q1 FY2025 (2024-09-29) | Q2 FY2025 (2024-12-29) | Q3 FY2025 (2025-03-30) | Q1 FY2026 (2025-09-28) | Q2 FY2026 (2025-12-28) | Q3 FY2026 (2026-03-29) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [16.6](/filings/0001140361-23-051013.md) | [16.4](/filings/0001140361-24-005023.md) | [14.2](/filings/0001140361-24-023848.md) | [14.8](/filings/0001140361-24-045542.md) | [14.5](/filings/0001140361-25-003278.md) | [14.7](/filings/0001140361-25-017905.md) | [14.8](/filings/0001140361-25-040686.md) | [14.7](/filings/0001140361-26-003800.md) | [14.5](/filings/0001140361-26-019447.md) | [14.3](/filings/0001140361-25-040686.md) | [14.3](/filings/0001140361-26-003800.md) | [14.3](/filings/0001140361-26-019447.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 14,211,566 at 2026-09-17, from the cover of the [10-K filed 2026-09-24](/filings/0001140361-26-037514.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:22 ET. No prices; not investment advice.